Complete Estrogen Blockade for the Treatment of Metastatic and Early Stage Breast Cancer

Author： Michaud L.B.   Buzdar A.U.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.16, Iss.4, 2000-04, pp. : 261-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality-of-Life Considerations in the Treatment of Early-Stage Breast Cancer in the Elderly

By Reimer Toralf   Gerber Bernd  

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 791-800

Adis International

Access to resources Recommend Favorite

Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing

By Simoens Steven  

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 807-809

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use in the Management of HER2-Positive Metastatic and Early-Stage Breast Cancer

By Plosker Greg L.   Keam Susan J.  

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 449-475

Adis International

Access to resources Recommend Favorite

Treatment of Estrogen Receptor-Positive Breast Cancer

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 596-604

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Treatment Stratification for Metastatic Breast Cancer

By Barton Sarah   Swanton Charles  

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2099-2113

Adis International

Access to resources Recommend Favorite